Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Table 2 Plasma protein levels in different study groups
Control (n = 30) | Benign (n = 10) | Malignant (n = 50) | P value | |
Cancer antigen 125 (U/mL) | 12.2 (3.1-25.9)a | 28.6 (3.5-1217)b | 232 (5.5-3649)c | < 0.001 |
Human epididymis protein 4 (pmol/L) | 41.6 (3.8-83.8)a | 93.4 (37-800)b | 283 (37-5908)b | < 0.001 |
Insulin-like growth factors-binding proteins 2 (pg/mL) | 273 (117-353)a | 2641 (1114-3773)b | 2669 (146-5785)b | < 0.001 |
Thrombospondin 1 protein (pg/mL) | 2899 (95-8500) | 1702 (560-3540) | 1803 (92-8500) | 0.051 |
Secreted phosphoprotein 1 (ng/mL) | 4.2 (1.9-6.3)a | 3.98 (0.85-11.5)a | 40.4 (11-76.5)b | < 0.001 |
D-dimer (ng/mL) | 0.1 (0-0.5)a | 832 (262-3429)b | 744 (50-1000)b | < 0.001 |
- Citation: Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107711.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107711